Status:
RECRUITING
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
HIV Infections
Antiretroviral Agents
Eligibility:
All Genders
18+ years
Brief Summary
HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities...
Detailed Description
The survival of people living with HIV (PLHIV) taking antiretroviral therapy (ART) is now close to what is reported in the general population in northern countries. However, PLHIV experience an increa...
Eligibility Criteria
Inclusion
- Patients aged over 18 years old.
- Confirmed HIV infection
- Signed informed consent
Exclusion
- HIV-2 infection
Key Trial Info
Start Date :
July 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
7200 Patients enrolled
Trial Details
Trial ID
NCT03296202
Start Date
July 18 2017
End Date
July 1 2025
Last Update
February 21 2025
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
service de médecine interne - CH d'Agen
Agen, France, 47923
2
Médecine interne - CH d'Angoulême
Angoulême, France
3
service de maladies infectieuses - CH de la Côte Basque
Bayonne, France, 64109
4
service de médecine inter et maladies infectieuses - Hopital Saint André
Bordeaux, France, 33075